Please login to the form below

transplants

This page shows the latest transplants news and features for those working in and with pharma, biotech and healthcare.

This includes those who have received organ transplants or those with blood cancer.

Gilead’s CAR-T cell therapy recommended by NICE for lymphoma

dose chemotherapy and a stem cell transplant. ... Of those who receive a transplant, about 50% will relapse. While there is currently no standard treatment for DLBCL or PMBCL after two or more systemic therapies, this decision from NICE
Ipsen to acquire rare disease specialist Albireo in deal worth over $950m

Bylvay is also currently in phase 3 development for biliary atresia (BA), the most common of three main paediatric liver diseases and the leading cause of liver transplants for children.
Jasper Therapeutics’ briquilimab given orphan drug designation in EU

The drug will be used for transplant patients with SCID, AML and MDS. ... The company’s president and chief executive officer, Ronald Martell, said: “Transplants have the potential to cure several haematologic cancers and genetically inherited
EC approves Atara and Pierre Fabre’s Ebvallo as monotherapy for Epstein-Barr patients

age and older with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD). ... The authorisation is specifically for those who have either received at least one prior therapy, or for solid organ
NHS England set to be first in world to eliminate hepatitis C by 2030

transplants. Within six years, this number is down by two-thirds and the number of annual registrations for a liver transplant in patients with hepatitis C related diseases reduced from over

More from news
Approximately 12 fully matching, plus 290 partially matching documents found.

LifeArc’s challenge to combat bronchiectasis

see their lung function deteriorate over time to the point they may need a lung transplant.
My journey advancing the science in pulmonary hypertension

At the time the only realistic treatment option for her was a heart and lung transplant, which is a risky procedure. ... Luckily, she received the transplant quickly and recovered well. After her transplant, Julia was determined not only to fight PH, but
How COVID-19 is accelerating the threat of antimicrobial resistance

AMR threatens our ability to treat common infections and increases the risk of medical procedures such as transplants, chemotherapy, chronic disease management and major surgery.
Keeping up the fight against HIV and using the lessons to tackle other threats

being labelled as the next public health crisis – NASH now outstrips alcohol as the most prevalent cause of liver transplants in the United States. ... The data is still evolving but, as obesity grows, fatty liver disease is becoming more common and a
Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

Its only immediate competition will be donor stem cell transplants, which carry significant patient risks. ... LentiGlobin provides an allogeneic alternative to autologous transplants. Instead of using donor cells, the patient’s own cells are harvested,

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Weekly industry appointments

There, he is medicines development leader for adenosine deaminase deficiency (ADA-SCID) gene therapy Strimvelis – the first alternative medicine to stem cell transplant for the disease that’s bagged a regulatory
Astellas strengthens US and Canadian leadership team

cardiovascular and transplant franchises.
Nektar Therapeutics appoints Jeff Ajer

Prior to BioMarin, Ajer served as vice president, global transplant operations at Genzyme Corporation, and has held roles in sales, marketing and operations at SangStat Medical Corporation and ICN Pharmaceuticals.
Sam Agus takes up new role at Hansa Medical

on building an effective company strategy around the global market for the launch of IdeS – a project based on kidney transplants in sensitised patients.
Polyphor appoints new chief medical and development officer

Dr Baker arrives at Polyphor from Novartis, where she held several positions including global head of medical affairs, development head for infectious diseases, transplants and immunology, and global head of clinical

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Action on Anti-microbial resistance: Will the UK rise to the challenge

Timely and effective antimicrobials are the cornerstone of our healthcare systems, providing life-saving treatment and supporting vital services like routine operations, transplants and cancer treatment. ... These medicines underpin everyday life-saving
Personalized Oncology: Calling for a New Kind of Partnership:

As much as past predictions of whole organ transplants and intra-body cameras have been realized, the notion of using measuring an array of protein to better understand a patient’s
Changing healthcare, one film at a time

Jennie Jewitt-Harris, Chief Executive of Transplant Links Charity, notes that “there’s an opportunity to really connect with people who are living out these awful and difficult situations, and show
HARNESSING TECHNOLOGY TO TRANSFORM HEALTHCARE IN THE DIGITAL AGE

The bionic hybrid heart was developed for use by engineers, rather than for use as a transplant organ, however the applications are no less impressive.
Hanover Communications

Timely and effective antimicrobials are the cornerstone of our healthcare systems, providing life-saving treatment and supporting vital services like routine operations, transplants and cancer treatment.

More from PMHub
Approximately 2 fully matching, plus 20 partially matching documents found.

Associate Director - Global Healthcare Consulting: £100,000 - £115,000 yearly

Early Access Program - Regulatory Affairs (EAP-RA): Highly competitive salary

Add my company

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Time to talk about health inequalities: Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
The speed of science and the pace of comms: Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
Improving cardiovascular disease care and awareness: Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...

Email:
Password: